Biotechnology & Synthetic Biology
Programming life: CRISPR, protein design, biofoundries, biomaterials
Overview
Programming and engineering living systems. CRISPR gene therapies, designed proteins, biological fermentation, bio-inspired materials.
Impact: Cures for genetic diseases, exajoule-scale bioproduction, new materials, zero-waste manufacturing
Involved actors
Projects
Active
Editas Medicine — CRISPR Gene Therapy
Pipeline of 20+ indications. First approvals 2024-2025, aggressive expansion 2026+.
52% — 2025-2026
DeepMind — AlphaFold & Protein Design
AlphaFold across every problem. Massive drug discovery acceleration. Custom-designed therapeutics.
65% — 2027-2028
Intrexon (Precigen) — Biomanufacturing
Bio-manufacturing at scale. Chemicals, fuels, materials via optimized fermentation.
48% — 2027-2028
Mylo & Bolt Threads — Biomaterials
Producing otherwise impossible materials via fermentation. Sustainable, high-performance fashion.
58% — 2026-2027
Genentech & Collaborators — mRNA Therapeutics
Expansion beyond COVID. RSV approval, influenza clinical data, cancer vaccines in Phase 2/3.
55% — 2026-2027